Marit Stirnberg - Search Results

Year	Number of Results
2006	2
2007	1
2010	4
2011	3
2012	3
2013	3
2015	6
2016	7
2017	4
2018	1
2024	0

1

Development of nitrile-based peptidic inhibitors of cysteine cathepsins.

Frizler M, Stirnberg M, Sisay MT, Gütschow M. Frizler M, et al. Among authors: stirnberg m. Curr Top Med Chem. 2010;10(3):294-322. doi: 10.2174/156802610790725452. Curr Top Med Chem. 2010. PMID: 20166952 Review.

2

Ectodomain shedding of CD99 within highly conserved regions is mediated by the metalloprotease meprin β and promotes transendothelial cell migration.

Bedau T, Peters F, Prox J, Arnold P, Schmidt F, Finkernagel M, Köllmann S, Wichert R, Otte A, Ohler A, Stirnberg M, Lucius R, Koudelka T, Tholey A, Biasin V, Pietrzik CU, Kwapiszewska G, Becker-Pauly C. Bedau T, et al. Among authors: stirnberg m. FASEB J. 2017 Mar;31(3):1226-1237. doi: 10.1096/fj.201601113R. Epub 2016 Dec 21. FASEB J. 2017. PMID: 28003343

3

Evaluation of bisbenzamidines as inhibitors for matriptase-2.

Beckmann AM, Gilberg E, Gattner S, Huang TL, Vanden Eynde JJ, Mayence A, Bajorath J, Stirnberg M, Gütschow M. Beckmann AM, et al. Among authors: stirnberg m. Bioorg Med Chem Lett. 2016 Aug 1;26(15):3741-5. doi: 10.1016/j.bmcl.2016.05.071. Epub 2016 May 26. Bioorg Med Chem Lett. 2016. PMID: 27287367

4

Matriptase-2, a regulatory protease of iron homeostasis: possible substrates, cleavage sites and inhibitors.

Stirnberg M, Gütschow M. Stirnberg M, et al. Curr Pharm Des. 2013;19(6):1052-61. doi: 10.2174/1381612811319060007. Curr Pharm Des. 2013. PMID: 23016685 Review.

5

A Short Peptide Inhibitor as an Activity-Based Probe for Matriptase-2.

Mangold M, Gütschow M, Stirnberg M. Mangold M, et al. Among authors: stirnberg m. Pharmaceuticals (Basel). 2018 May 21;11(2):49. doi: 10.3390/ph11020049. Pharmaceuticals (Basel). 2018. PMID: 29883401 Free PMC article.

6

A Fluorescent-Labeled Phosphono Bisbenzguanidine As an Activity-Based Probe for Matriptase.

Häußler D, Schulz-Fincke AC, Beckmann AM, Keils A, Gilberg E, Mangold M, Bajorath J, Stirnberg M, Steinmetzer T, Gütschow M. Häußler D, et al. Among authors: stirnberg m. Chemistry. 2017 Apr 19;23(22):5205-5209. doi: 10.1002/chem.201700319. Epub 2017 Mar 28. Chemistry. 2017. PMID: 28370501

7

Inhibitors of Matriptase-2 Based on the Trypsin Inhibitor SFTI-1.

Gitlin A, Dębowski D, Karna N, Łęgowska A, Stirnberg M, Gütschow M, Rolka K. Gitlin A, et al. Among authors: stirnberg m. Chembiochem. 2015 Jul 27;16(11):1601-7. doi: 10.1002/cbic.201500200. Epub 2015 Jun 19. Chembiochem. 2015. PMID: 25999208

8

Identification of the first low-molecular-weight inhibitors of matriptase-2.

Sisay MT, Steinmetzer T, Stirnberg M, Maurer E, Hammami M, Bajorath J, Gütschow M. Sisay MT, et al. Among authors: stirnberg m. J Med Chem. 2010 Aug 12;53(15):5523-35. doi: 10.1021/jm100183e. J Med Chem. 2010. PMID: 20684597

9

A Bisbenzamidine Phosphonate as a Janus-faced Inhibitor for Trypsin-like Serine Proteases.

Häußler D, Scheidt T, Stirnberg M, Steinmetzer T, Gütschow M. Häußler D, et al. Among authors: stirnberg m. ChemMedChem. 2015 Oct;10(10):1641-6. doi: 10.1002/cmdc.201500319. Epub 2015 Aug 25. ChemMedChem. 2015. PMID: 26306030

10

The intact Kunitz domain protects the amyloid precursor protein from being processed by matriptase-2.

Beckmann AM, Glebov K, Walter J, Merkel O, Mangold M, Schmidt F, Becker-Pauly C, Gütschow M, Stirnberg M. Beckmann AM, et al. Among authors: stirnberg m. Biol Chem. 2016 Aug 1;397(8):777-90. doi: 10.1515/hsz-2015-0263. Biol Chem. 2016. PMID: 27078672

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

29 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year